Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BLSM
BLOSSOMHILL THERAPEUTICS, INC.
NASDAQ
$16.38
▲ UP 3.67% (0.58)

KEY STATISTICS

Market Cap$476.35 M
52w High$17.25
52w Low$15.25
Dividend Yield—
Frequency—
P/E—
Volume111.39K
Shares Out.29.08M

COMPANY

LEADERSHIP

Jing Rong Jean Cui
CHIEF EXECUTIVE
Jing Rong Jean Cui

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 7, 2026
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
63

PRICE

$16.38 ▲ UP 3.67% (+$0.58)
$15.80$16.00$16.20$16.409:33 AM10:37 AM11:42 AM12:46 PM1:50 PM2:55 PM3:59 PM16.38

About BlossomHill Therapeutics, Inc.

http://www.bhtherapeutics.com ↗

Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.

INDUSTRY

Biotechnology

A PRODUCT BLOSSOMHILL THERAPEUTICS, INC. IS KNOWN FOR

BH-30643
BH-30643

BH-30643 is an investigational, orally bioavailable, mutant-selective OMNI-EGFR™ inhibitor in Phase 1/2 trials for NSCLC patients with EGFR or HER2 mutations.

COMPETITORS

COMPETITOR
AMGN COMPARE
AZN COMPARE
BDTX COMPARE
CGEM COMPARE
JNJ COMPARE

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity4
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2